Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
(NQ:
)
N/A
UNCHANGED
Last Price
Updated:
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
-
Bid (Size)
N/A (0)
Ask (Size)
N/A (0)
Prev. Close
-
Today's Range
N/A - N/A
52wk Range
N/A - N/A
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
Top News
More News
Lexicon Announces Selection Of Manuscript To Be Presented At The American Diabetes Association Diabetes Care Symposium
May 12, 2015
Results from Clinical Study of Sotagliflozin in Type 1 Diabetes Patients
From
PR Newswire
Lexicon to Present at the Bank of America Merrill Lynch 2015 Health Care Conference
May 07, 2015
From
PR Newswire
Performance
More News
Read More
Lexicon Announces One For Seven Reverse Stock Split Effective May 20, 2015
April 29, 2015
From
PR Newswire
Lexicon Pharmaceuticals Provides Clinical Pipeline Update And Reports 2015 First Quarter Financial Results
April 29, 2015
From
PR Newswire
Lexicon To Report First Quarter 2015 Financial Results On April 29, 2015
April 27, 2015
From
PR Newswire
Market Updates on Biotech Stocks -- Lexicon Pharma, Idera Pharma, Synta Pharma, Spectrum Pharma, and Medivation
April 27, 2015
From
PR Newswire
Lexicon Pharmaceuticals and Bristol-Myers Squibb Select Development Candidate for Neuropathic Pain in Neuroscience Drug Discovery and Development Alliance
April 15, 2015
From
PR Newswire
Lexicon To Present At Needham & Company's 14th Annual Healthcare Conference
April 09, 2015
From
PR Newswire
Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) to Ring The Nasdaq Stock Market Closing Bell
April 07, 2015
From
GlobeNewswire News Releases
Lexicon Pharmaceuticals Announces First Patient Screened In Pivotal Phase 3 Clinical Trial Of Sotagliflozin
March 25, 2015
From
PR Newswire
Technical Pulse on Biotech Stocks -- Geron, Lexicon Pharma, XOMA Corp., Spectrum Pharma, and BioLine RX
March 23, 2015
From
PR Newswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.